Investing Ideas
/
Swedish Healthcare Undervalued Stocks Based On Cash Flows

Swedish Healthcare Undervalued Stocks Based On Cash Flows

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

8 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
EKTA B Elekta	SEK 60.25	-9.9%	-19.0%	SEK 23.0b	SEK 73.31	PE23x	E21.3%	2.0%
SUS Surgical Science Sweden	SEK 159.40	-15.9%	2.8%	SEK 8.1b	SEK 193.00	PE61.8x	E36.7%	n/a
CARA Carasent	SEK 22.80	-4.8%	n/a	SEK 1.6b	SEK 25.19	PS6.3x	E89.1%	7.7%
STIL Stille	SEK 238.00	-5.6%	48.3%	SEK 2.1b	SEK 272.00	PE36.7x	E23.8%	0%
SYNT SyntheticMR	SEK 27.70	0%	-13.4%	SEK 1.2b	SEK 30.00	PE115.3x	E47.4%	0%
HUM Humana	SEK 45.50	8.9%	76.0%	SEK 2.4b	SEK 50.50	PE16.4x	E30.9%	2.2%
VIMIAN Vimian Group	SEK 43.40	-5.5%	50.6%	SEK 22.7b	SEK 46.63	PE110.4x	E44.3%	n/a
CEVI CellaVision	SEK 186.00	-5.1%	-27.3%	SEK 4.4b	SEK 242.50	PE31.5x	E20.7%	1.3%

Page 1 of 1